Approvals/TGA/DUPIXENT dupilumab (rch) 300 mg/2 mL solution for injection pre-filled syringe with needle shield

Approved

STANDARD

DUPIXENT dupilumab (rch) 300 mg/2 mL solution for injection pre-filled syringe with needle shield

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: a34d4b2f82da1b90
Product Name: DUPIXENT dupilumab (rch) 300 mg/2 mL solution for injection pre-filled syringe with needle shield
Artg Id: 283127
Artg Name: DUPIXENT dupilumab (rch) 300 mg/2 mL solution for injection pre-filled syringe with needle shield
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2018-01-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/30fd823fe34d32cf01f3171c22464510.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/ffdf4d845b4cf3bb2db817e2109e341f.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

a34d4b2f82da1b90

Type

Standard